1. Home
  2. AWH

AWH

Aspira Women's Health Inc.

Logo Aspira Women's Health Inc.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

Founded: 1993 Country:
United States
United States
Employees: N/A City: AUSTIN
Market Cap: 41.8M IPO Year: N/A
Target Price: $4.45 AVG Volume (30 days): 32.3K
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.81 EPS Growth: N/A
52 Week Low/High: $2.31 - $6.75 Next Earning Date: 05-09-2024
Revenue: $9,154,000 Revenue Growth: 11.85%
Revenue Growth (this year): 21.01% Revenue Growth (next year): 79.36%

Share on Social Networks: